Align Technology, Inc. (ALGN) — Fair Value Analysis

Base-case fair value (P50): $191.34 · Current price: $184.52 · Verdict: Fairly Valued

The Verdict on ALGN

Align Technology (ALGN) is currently assessed as undervalued by our proprietary Monte Carlo simulations. These simulations, which project thousands of forward-looking financial scenarios, establish a median fair value (P50) for ALGN at $191.34. This outcome significantly exceeds the current trading price of $184.52, indicating a potential +3.7% upside for investors. The robust nature of these simulations provides a comprehensive view, suggesting that ALGN's intrinsic value, derived from its strong operational and financial health, is not fully reflected in its present market valuation. This clear verdict positions ALGN as a potentially attractive opportunity within the dynamic Healthcare sector.

How ALGN stacks up against Healthcare

ALGN distinguishes itself within the competitive Healthcare sector by maintaining a strong quality tier. This designation signifies Align Technology's superior operational and financial health when benchmarked against its industry peers. Such fundamental strength is a key driver in the Monte Carlo simulations, underpinning the projected median fair value of $191.34. While the market currently prices ALGN at $184.52, our models suggest this valuation does not fully capture the inherent resilience and growth potential supported by its strong fundamentals. The resulting +3.7% discrepancy highlights the market's potential oversight of ALGN's quality and long-term prospects.

What this means for investors

For investors analyzing Align Technology, the pronounced +3.7% potential identified through our Monte Carlo analysis warrants close attention. With ALGN trading at $184.52 against a statistically derived median fair value of $191.34, the current market price presents a compelling entry point based on our models. Our simulations comprehensively model both plausible upside and downside scenarios; the central finding consistently points to ALGN being undervalued. To gain a deeper understanding of the full probabilistic distribution, including specific bear case (P10) and bull case (P90) targets, and to track daily fair-value updates as new fundamentals are released, sign up for a free FairCurve account.